Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • SciSure Reviews & Ratings
    4.2 out of 5 stars 311 Ratings
    Company Website for SciSure
  • StackAI Reviews & Ratings
    4.5 out of 5 stars 55 Ratings
    Company Website for StackAI
  • Healthee Reviews & Ratings
    4.6 out of 5 stars 13 Ratings
    Company Website for Healthee
  • Eurekos Reviews & Ratings
    4.8 out of 5 stars 103 Ratings
    Company Website for Eurekos
  • Nalpeiron Zentitle Reviews & Ratings
    4.8 out of 5 stars 31 Ratings
    Company Website for Nalpeiron Zentitle
  • AthenaHQ Reviews & Ratings
    4.9 out of 5 stars 50 Ratings
    Company Website for AthenaHQ
  • FrameworkLTC Reviews & Ratings
    4.4 out of 5 stars 48 Ratings
    Company Website for FrameworkLTC
  • JDisc Discovery Reviews & Ratings
    4.8 out of 5 stars 30 Ratings
    Company Website for JDisc Discovery
  • Criminal IP ASM Reviews & Ratings
    4.9 out of 5 stars 21 Ratings
    Company Website for Criminal IP ASM
  • Gushwork Reviews & Ratings
    4.5 out of 5 stars 29 Ratings
    Company Website for Gushwork

What is Recursion?

Recursion is a pioneering TechBio company reimagining drug discovery through the integration of biology, artificial intelligence, and large-scale data. Founded more than ten years ago, Recursion introduced a novel approach that uses cellular imaging to train AI models to understand disease mechanisms. The company’s mission is to reduce the high failure rate of traditional drug development by uncovering deeper biological insights. At the core of its work is the Recursion OS, a drug discovery and development platform that unifies data, machine learning, and automated experimentation. Recursion has built one of the world’s largest proprietary biological and chemical datasets, spanning phenomics, transcriptomics, proteomics, and patient data. Its automated wet labs generate millions of experiments weekly, creating a continuous feedback loop that improves model performance. This system enables rapid identification of new drug targets and optimized molecule design. Recursion’s pipeline includes multiple programs addressing aggressive cancers and rare diseases with significant unmet needs. The company partners with pharmaceutical leaders, computational technology providers, and data innovators to extend its impact. With BioHive-2, a powerful supercomputer built with NVIDIA, Recursion processes massive datasets at unprecedented speed. These capabilities allow the company to move candidates faster from discovery to clinical trials. Overall, Recursion is focused on delivering better medicines to patients through AI-driven precision and scale.

What is BenevolentAI?

BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Standard Support
Web-Based Support

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Documentation Hub
On-Site Training

Training Options

Documentation Hub
Online Training

Company Facts

Organization Name

Recursion

Company Location

United States

Company Website

www.recursion.com

Company Facts

Organization Name

BenevolentAI

Date Founded

2013

Company Location

Luxembourg

Company Website

www.benevolent.com

Categories and Features

AI Science

Not specified

Drug Discovery

Not specified

Healthcare AI

Not specified

Categories and Features

AI Science

Not specified

Drug Discovery

Not specified

Life Sciences

Not specified

Popular Alternatives

Popular Alternatives

Scitara DLX Reviews & Ratings

Scitara DLX

Scitara